Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
(Recasts to lead with vaccine approval)MADRID, Feb 5 (Reuters) - Spain approved AstraZeneca's coronavirus vaccine for use in people aged 18 to 55 on Friday, becoming the latest country to limit the shot to younger people due to a lack of data on i...
Read more(Adds background, vaccine decision)MADRID, Feb 5 (Reuters) - Madrid health authorities on Friday confirmed the region's first case of the Brazilian COVID-19 variant, while a national committee was debating whether to recommend AstraZeneca's vaccin...
Read more
TOP NEWS: AstraZeneca Vaccine Effective Against UK Variant
Read more(Adds quote, details)KYIV, Feb 5 (Reuters) - Ukraine has secured from the Serum Institute of India 12 million coronavirus vaccine doses developed by AstraZeneca and Novavax, President Volodymyr Zelenskiy's office said.The announcement is a breakth...
Read more(Adds details, background, comment from U.S. trial investigator)LONDON, Feb 5 (Reuters) - AstraZeneca expects to have results from a U.S. clinical trial of its COVID-19 vaccine in the next four to six weeks, the company's research chief Mene Pang...
Read more(Adds details,)BUDAPEST, Feb 5 (Reuters) - The Czech Republic may consider using vaccines not yet registered in the EU to speed up inoculations, Prime Minister Andrej Babis said on Friday, on a trip to Hungary which has given emergency approval to...
Read moreKYIV, Feb 5 (Reuters) - Ukraine has secured, from the Serum Institute of India, 12 million coronavirus vaccine doses developed by AstraZeneca and Novavax, President Volodymyr Zelenskiy's office said in a statement. (Reporting by Pavel Polityuk; w...
Read moreLONDON, Feb 5 (Reuters) - AstraZeneca expects results from the U.S. clinical trial of its COVID-19 vaccine in the next four to six weeks, the pharma firm's research chief Mene Pangalos said on Friday.Asked about when the U.S. trial results would b...
Read more(Adds detail, quote, background)LONDON, Feb 5 (Reuters) - AstraZeneca and Oxford University's COVID-19 vaccine has similar efficacy against the British coronavirus variant as it does to the previously circulating variants, the university said on F...
Read moreLONDON, Feb 5 (Reuters) - AstraZeneca and Oxford University's COVID-19 vaccine has similar efficacy against the "Kent" coronavirus variant currently circulating in Britain as it does to the previously circulating variants, the university said on ...
Read more
(Sharecast News) - Ongoing safety checks by the UK regulator confirmed the safety of Covid-19 vaccines.
Read more(Adds details, context)By Emilio ParodiMILAN, Feb 5 (Reuters) - If vaccine supplies are confirmed, seven million Italians could be fully vaccinated against COVID-19 by the end of March, the government's special commissioner Domenico Arcuri said on...
Read more(Adds details)MILAN, Feb 5 (Reuters) - If vaccine supplies will be confirmed, seven million Italians could be fully vaccinated against COVID-19 by the end of the March, the government's special commissioner Domenico Arcuri said on Friday.Arcuri sa...
Read more(Adds Oxford on UK variant)LONDON, Feb 5 (Reuters) - British regulators have received extra trial data from AstraZeneca that supports their view that the COVID-19 vaccine developed with Oxford University is effective in the elderly, a vaccines off...
Read more(Adds extra detail, quotes)LONDON, Feb 5 (Reuters) - British regulators have received extra trial data from AstraZeneca that supports their view that the COVID-19 vaccine developed with Oxford University is effective in the elderly, a vaccines off...
Read more
Last checked at